171 related articles for article (PubMed ID: 17641969)
21. Incidence of renal replacement therapy in Veneto for 2008, 2009 and 2010.
Nordio M; Tessitore N; Feriani M; Rossi B; Virga G; Amici G; Abaterusso C; Antonucci F;
J Nephrol; 2013; 26 Suppl 20():S3-12. PubMed ID: 24293193
[TBL] [Abstract][Full Text] [Related]
22. Risk factor and cost accounting analysis for dialysis patients in Taiwan.
Su BG; Tsai KL; Yeh SH; Ho YY; Liu SY; Rivers PA
Health Serv Manage Res; 2010 May; 23(2):84-93. PubMed ID: 20424276
[TBL] [Abstract][Full Text] [Related]
23. [Italian Registry of Dialysis and Transplantation: 1996-2001 experience].
Conte F; Cappelli G; Casino F; Postorino M; Quintaliani G; Salomone M; Di Napoli A; Limido A; Mancini E; Nordio M; Pinna A; Santoro D; Alloatti S; Bellinghieri G; Bonadonna A; Bonomini M; Colasanti G; Di Giulio S; Di Iorio B; Di Lallo D; Gaffi G; Gesualdo L; Locatelli F; Piccoli G; Quarello F; Riegler P; Salvadori M; Santoro A; Sparano G; Vasile A;
G Ital Nefrol; 2004; 21(6):561-7. PubMed ID: 15593024
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and direct medical costs of end-stage renal disease in patients with type 2 diabetes mellitus in Switzerland for 2001.
Sandoz MS; Ess SM; Keusch GW; Schwenkglenks M; Szucs TD
Swiss Med Wkly; 2004 Aug; 134(31-32):448-58. PubMed ID: 15389348
[TBL] [Abstract][Full Text] [Related]
25. End stage renal disease.
Greer J
Health Care Financ Rev Annu Suppl; 1992; ():199-205. PubMed ID: 10131707
[No Abstract] [Full Text] [Related]
26. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
Prodjosudjadi W
Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
[TBL] [Abstract][Full Text] [Related]
27. The Challenge of Providing Renal Replacement Therapy in Developing Countries: The Latin American Perspective.
Obrador GT; Rubilar X; Agazzi E; Estefan J
Am J Kidney Dis; 2016 Mar; 67(3):499-506. PubMed ID: 26709109
[TBL] [Abstract][Full Text] [Related]
28. Access to and coverage of renal replacement therapy in minorities and ethnic groups in Venezuela.
Bellorin-Font E; Pernalete N; Meza J; Milanes CL; Carlini RG
Kidney Int Suppl; 2005 Aug; (97):S18-22. PubMed ID: 16014094
[TBL] [Abstract][Full Text] [Related]
29. Global variation in renal replacement therapy for end-stage renal disease.
Caskey FJ; Kramer A; Elliott RF; Stel VS; Covic A; Cusumano A; Geue C; Macleod AM; Zwinderman AH; Stengel B; Jager KJ
Nephrol Dial Transplant; 2011 Aug; 26(8):2604-10. PubMed ID: 21245131
[TBL] [Abstract][Full Text] [Related]
30. Differences and inequalities in relation to access to renal replacement therapy in the BRICS countries.
Ferraz FHRP; Rodrigues CIS; Gatto GC; Sá NM
Cien Saude Colet; 2017 Jul; 22(7):2175-2185. PubMed ID: 28724000
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of end-stage renal disease in an interregional perspective: Registries of Puglia and Basilicata, southern Italy.
Vitullo F; Casino FG; Di Matteo A; Di Candia VD; Gaudiano V; Piras V; Alfonso L; Basile C; Procaccini DA; Gesualdo L;
J Nephrol; 2003; 16(6):813-21. PubMed ID: 14736008
[TBL] [Abstract][Full Text] [Related]
32. The databases: renal replacement therapy since 1989--the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA).
Zoccali C; Kramer A; Jager K
Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S18-22. PubMed ID: 19996000
[TBL] [Abstract][Full Text] [Related]
33. [Organizational models in the Italian nephrology, dialysis and transplantation network].
Manno C; Zuccalà A
G Ital Nefrol; 2013; 30(3):. PubMed ID: 23832472
[TBL] [Abstract][Full Text] [Related]
34. The Latin American Dialysis and Transplantation Registry (RLDT) annual report 2004.
Cusumano A; Garcia GG; Di Gioia C; Hermida O; Lavorato C;
Ethn Dis; 2006; 16(2 Suppl 2):S2-10-3. PubMed ID: 16774002
[TBL] [Abstract][Full Text] [Related]
35. High-cost life prolongation: the National Kidney Dialysis and Kidney Transplantation Study.
Gutman RA
Ann Intern Med; 1988 Jun; 108(6):898-9. PubMed ID: 3285750
[No Abstract] [Full Text] [Related]
36. Technical-economic management models in dialytic treatment: an evolving reality. The Italian experience.
Locatelli F; Pontoriero G; Del Vecchio L; Conte F
J Nephrol; 2000; 13 Suppl 3():S20-7. PubMed ID: 11132029
[TBL] [Abstract][Full Text] [Related]
37. End-stage renal failure and national resources: the Brazilian experience.
Zatz R; Romão JE
Ren Fail; 2006; 28(8):627-9. PubMed ID: 17162419
[TBL] [Abstract][Full Text] [Related]
38. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
39. Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy.
Mignani R; Feriozzi S; Pisani A; Cioni A; Comotti C; Cossu M; Foschi A; Giudicissi A; Gotti E; Lozupone VA; Marchini F; Martinelli F; Bianco F; Panichi V; Procaccini DA; Ragazzoni E; Serra A; Soliani F; Spinelli L; Torti G; Veroux M; Cianciaruso B; Cagnoli L
Nephrol Dial Transplant; 2008 May; 23(5):1628-35. PubMed ID: 18057066
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of renal replacement therapy in Veneto for 2008, 2009 and 2010.
Nordio M; Tessitore N; Feriani M; Rossi B; Amici G; Virga G; Abaterusso C; Antonucci F;
J Nephrol; 2013; 26 Suppl 20():S13-22. PubMed ID: 24293194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
